ESC Congress 2017

26 - 30 August 2017, Barcelona - Spain

Session Details

Late-Breaking Science in Heart Failure
Mon 28 Aug 08:30 - 10:00 Heart failure, other Late-Breaking Science Warsaw - Village 9
Chairpersons: Frank RUSCHITZKA (Zurich, Switzerland), Milton PACKER (Dallas, United States of America)

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
08:302956Heart failure and death in new users of SGLT2 inhibitors vs other glucose-lowering drugs - consistent risk reduction across patient groups in 4 countries and >270,000 patients: The CVD-REAL StudyAnna NORHAMMAR (Stockholm, Sweden)
08:452957Efficacy of beta-blockers in heart failure according to left ventricular ejection fraction: An individual patient level analysis of double-blind randomised trialsDipak KOTECHA (Birmingham, United Kingdom)
09:002958Marked variation in the efficacy of beta-blockers across cardiovascular health: A Global systematic assessment of mortality, myocardial infarction and strokeOliver ZIFF (London, United Kingdom)
09:152959Heart Failure-Wii studyTiny JAARSMA (Norrkoping, Sweden)
09:302960Does the risk for heart failure (HF) modulate the effectiveness of empagliflozin on HF hospitalisation or CV death in patients with type 2 diabetes without HF? Insights from EMPA-REG OUTCOME Javed BUTLER (Atlanta, United States of America)
09:452961Predicting right heart failure after implantation of continuous flow left ventricular assist devices (EUROMACS-RHF) score: analysis of the EUROMACS dataOsama Ibrahim SOLIMAN (Rotterdam, Netherlands)